Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Uveal Melanoma OncogeneCYSLTR2Encodes a Constitutively Active GPCR Highly Biased Toward Gq Signaling
Emilie Ceraudo, Mizuho Horioka, Jordan M. Mattheisen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2019)
Open Access | Times Cited: 13

Showing 13 citing articles:

Angiotensin and biased analogs induce structurally distinct active conformations within a GPCR
Laura M. Wingler, Meredith A. Skiba, Conor McMahon, et al.
Science (2020) Vol. 367, Iss. 6480, pp. 888-892
Open Access | Times Cited: 210
Heterotrimeric Gq proteins as therapeutic targets?
Evi Kostenis, Eva Marie Pfeil, Suvi Annala
Journal of Biological Chemistry (2020) Vol. 295, Iss. 16, pp. 5206-5215
Open Access | Times Cited: 71
Structural basis of ligand selectivity and disease mutations in cysteinyl leukotriene receptors
Anastasiia Gusach, Aleksandra Luginina, Egor Marin, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 68
Structure-Based Virtual Screening of Ultra-Large Library Yields Potent Antagonists for a Lipid GPCR
Arman Sadybekov, Rebecca L. Brouillette, Egor Marin, et al.
Biomolecules (2020) Vol. 10, Iss. 12, pp. 1634-1634
Open Access | Times Cited: 36
Involvement of mutant and wild-type CYSLTR2 in the development and progression of uveal nevi and melanoma
Rogier J. Nell, Nino V. Menger, Mieke Versluis, et al.
BMC Cancer (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 30
Update on GNA Alterations in Cancer: Implications for Uveal Melanoma Treatment
Lionel Larribère, Jochen Utikal
Cancers (2020) Vol. 12, Iss. 6, pp. 1524-1524
Open Access | Times Cited: 27
High Cysteinyl Leukotriene Receptor 1 Expression Correlates with Poor Survival of Uveal Melanoma Patients and Cognate Antagonist Drugs Modulate the Growth, Cancer Secretome, and Metabolism of Uveal Melanoma Cells
Kayleigh Slater, Aisling B. Heeran, Sandra García‐Mulero, et al.
Cancers (2020) Vol. 12, Iss. 10, pp. 2950-2950
Open Access | Times Cited: 25
The role of signaling pathways mediated by the GPCRs CysLTR1/2 in melanocyte proliferation and senescence
Thomas Huber, Mizuho Horioka, Yuanhuang Chen, et al.
Science Signaling (2024) Vol. 17, Iss. 854
Closed Access | Times Cited: 2
Small-wedge synchrotron and serial XFEL datasets for Cysteinyl leukotriene GPCRs
Egor Marin, Aleksandra Luginina, Anastasiia Gusach, et al.
Scientific Data (2020) Vol. 7, Iss. 1
Open Access | Times Cited: 7
High Cysteinyl Leukotriene Receptor 1 Expression Correlates with Poor Survival of Uveal Melanoma Patients and Cognate Antagonist Drugs Modulate the Growth, Cancer Secretome, and Metabolism of Uveal Melanoma Cells
Kayleigh Slater, Aisling B. Heeran, Rebeca Sanz‐Pamplona, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 4
Constitutive activity of GPR26 regulated by ubiquitin‐dependent degradation and its antitumor role
Fang Liu, Wei Yang, Minghui Hu, et al.
FEBS Journal (2021) Vol. 288, Iss. 15, pp. 4655-4682
Open Access | Times Cited: 1
Faculty Opinions recommendation of Heterotrimeric Gq proteins as therapeutic targets?
John Lowe
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature (2020)
Open Access
Protein design and crystallization trials for constitutively active CysLT2R with oncogenic L129Q mutation

(2022)
Open Access
Page 1

Scroll to top